KSR1 antisense oligonucleotide (Memorial Sloan-Kettering)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NameKSR1 antisense oligonucleotide (Memorial Sloan-Kettering)

Drug Alias NameKSR1 AS-ODNKSR1 antisense oligonucleotide (MSKCC)KSR1 antisense oligonucleotide (NCI)kinase suppressor of Ras1 antisense oligonucleotide (MSKCC)kinase supressor of Ras1 antisense oligonucleotide (Memorial Sloan-Kettering) +[7]

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionGTPase Ras inhibitors

TargetsGTPase Ras

Therapy Area/IndicationsPancreatic NeoplasmsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMemorial Sloan Kettering Cancer Center

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMemorial Sloan Kettering Cancer Center National Cancer Institute

Active IndicationsN/A

Inactive IndicationsPancreatic NeoplasmsNeoplasms

Other Information

ATC CodeN/A